William Blair


Abercrombie & Fitch Co. (ANF) Nixes Sale Talks; William Blair Weighs In

After months of preliminary deliberations with multiple bidders, including American Eagle and front runner Cerberus, Abercrombie & Fitch Co. (NYSE:ANF) revealed on Monday …

William Blair Shares Two Cents on Endo International plc (ENDP)

William Blair analyst Tim Lugo reiterates a Market Perform rating on shares of Endo International plc (NASDAQ:ENDP), following the news that the FDA has requested the …

Synthetic Biologics Inc (SYN) Cuts Through the Red Tape with Big FDA Win for Ribaxamase

Synthetic Biologics Inc (NYSEMKT:SYN) shares were rising almost 29% yesterday as the news took off that the biotech firm won a Breakthrough Therapy …

William Blair Tweaks Estimates For Gilead Sciences, Inc. (GILD) Ahead Of Q1 Print

As the earnings season kicks off for the biotechnology sector, William Blair analyst John Sonnier outlined updated earnings per share (EPS) estimates for Gilead …

BlackBerry Ltd (BBRY) Operating Segment Reorganization Leaves Room for Concerns

BlackBerry Ltd (NASDAQ:BBRY) shares were on a close to 12% surge Friday after the smartphone maker outclassed expectations across the board with its …

Endo International plc – Ordinary Shares (ENDP): Will Opana ER Be Out Off the Market Soon?

Endo International plc (NASDAQ:ENDP) is on investors’ radars after the FDA’s Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug …

William Blair Suggests Buying Finisar Corporation (FNSR) Shares On the Pullback

Finisar Corporation (NASDAQ:FNSR) is falling over 20% today after underwhelming investors with its fiscal third-quarter revenue, which came in $9 million below the consensus, and EPS …

William Blair Raises Red Flags on Endo International plc – Ordinary Shares (ENDP) Ahead of FDA AdCom for Opana ER Drug

William Blair analyst Tim Lugo is quite apprehensive on Endo International plc – Ordinary Shares (NASDAQ:ENDP) on the heels of yesterday morning’s review materials …

William Blair Bullish on Facebook Inc (FB) Following Meetings with Industry Executives

William Blair analyst Ralph Schackart is chiming in on Facebook Inc (NASDAQ:FB) following his meetings over the past month with an executive at …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts